Clinical Trials Browser

Phase 2 × Colorectal Neoplasms × dabrafenib × Clear all

NCT06978400 2025-05-18

A Study of Dabrafenib Plus Cetuximab/Panitumumab With FOLFOX in the First Line of Therapy in People With Metastatic Colorectal Cancer

Phase 2 Recruiting

Gastrointestinal

Neoplasms, Colorectal Neoplasms

NCT03668431 2022-06-27

Dabrafenib + Trametinib + PDR001 In Colorectal Cancer

Phase 2 Unknown

Gastrointestinal

Colorectal Neoplasms